United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary FibrosisBusiness Wire • 10/31/23
United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023Business Wire • 10/31/23
Miromatrix Medical stock soars after it agrees to be bought by United TherapeuticsMarket Watch • 10/30/23
Analysts Estimate United Therapeutics (UTHR) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/25/23
United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023Business Wire • 10/25/23
United Therapeutics: Both Fundamental And Technical Analyses Justify A Buy DecisionSeeking Alpha • 10/22/23
United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation ProgramsBusiness Wire • 09/22/23
United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit ReportBusiness Wire • 09/12/23
United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceBusiness Wire • 09/01/23
United Therapeutics: Eyeing A Re-Rating To 12-13x P/E, Growth More Than JustifiedSeeking Alpha • 08/03/23
United Therapeutics (UTHR) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 08/02/23
United Therapeutics (UTHR) Tops Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/02/23
United Therapeutics Corporation Reports Second Quarter 2023 Financial ResultsBusiness Wire • 08/02/23
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/26/23
United Therapeutics Corporation to Report Second Quarter 2023 Financial Results Before the Market Opens on Wednesday, August 2, 2023Business Wire • 07/26/23